Lack of association between -384 and 114 IL-2 gene polymorphisms and rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 3, 2003, Pages 435-437

  Fedetz, Maria ^a   Matesanz, Fuencisla ^a   Caliz, Rafael ^b   Ferrer, Miguel Angel ^b   Collado, Maria Dolores ^a   Alcina, Antonio ^a   Martin, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Gene; Interleukin 2; Promoter; Rheumatoid arthritis; Single nucleotide polymorphism; Susceptibility

Indexed keywords

INTERLEUKIN 12;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-2; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEVERITY OF ILLNESS INDEX;

EID: 0037333381     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-7.
2. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999;42:1071-9.
3. Feldman M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
4. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-51.
5. Horak I, Lohler J, Ma A, Smith KA. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 1995;148:35-44.
6. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL-2), IL-2 receptor and IFN-gamma. Clin Exp Immunol 1988;71:295-301.
7. Firestein GS, Xu WD, Townsend K, et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 1988;168:1573-86.
8. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
9. Ulfgren AK, Lindblad S, Klareskog L, Andersson J, Andersson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:654-6.
10. Wandstrat A, Wakeland E. The genetic of complex autoimmune diseases: non-MHC susceptibility genes. Nature Immunol 2001; 2:802-9.
11. Becker KG, Simon RM, Bailey-Wilson JE, et al. Clustering of nonmajor histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95:9979-84.
12. Encinas JA, Wicker LS, Peterson LB, et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing I12. Nature Genet 1999:21:158-60.
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Pascual M, Nieto A, Lopez-Nevot MA, et al. Rheumatoid arthritis in southern Spain: Towards a unifying role of the class II region in disease predisposition. Arthritis Rheum 2001;44:307-14.
15. Matesanz F, Fedetz M, Collado-Romero M, et al. Allelic expression and interleukin-2 polymorphism in multiple sclerosis. J Neurol Sci 2001:119:101-5.
16. Bidewell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line data base. Genes Immun 1999:1:3-19.
17. Bidewell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2001;2:61-70.
18. Bowcock AM, Kidd JR, Lathrop GM, et al. The human "interferon-B2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988;3:8-16.
19. Cox ED, Hoffmann SC, DiMercurio BS, et al. Cytokine polymorphic analyses indicates ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001;72:720-6.
20. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumor necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 2000;27:241-9.
21. John S, Turner D, Donn R, et al. Two novel biallelic polymorphism in the IL-2 gene. Eur J Immunogenet 1998;25:419-20.
22. Khani-Hanjani A, Hoar D, Horsman D, Lacaille D, Chalmers A, Keown P. Identification of four novel dinucleotide repeat polymorphisms in the IL-2 and IL-2β receptor genes. Hum Immunol 2001;62:368-70.
23. John S, Myerscough A, Marlow A, et al. Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity. Ann Rheum Dis 1998;57:361-5.
24. Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease susceptibility. Clin Exp Immunol 1998;113:28-32.
25. Jawaheer D, Seldin MF, Amos CI, et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001;68:927-36.